Sep 22, 2020
The Penn State Health Board of Directors voted unanimously last week to approve the leadership team’s recommendations about salary increases and a bonus payment for eligible Penn State Health employees.
Dr. Kevin Black, interim dean of Penn State College of Medicine, emailed College of Medicine faculty and staff regarding the College’s financial position.
Penn State Health St. Joseph presented DAISY (Diseases Attacking the Immune System) Awards to Rachel Drzewicki, a nurse in the Family Birthing Center, and Jennifer Schemberg, a nurse educator on 2N at the Bern campus.
Cassie Farrelly, MA, has been named director of operations and strategic initiatives for Penn State College of Medicine, effective Sept. 28, 2020.
Sep 21, 2020
A bike share program returned to Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine on Sept. 18, 2020. Participants can borrow from a pool of 40 Movatic bikes spread across nine stations.
In fall 2020, Penn State College of Medicine's medical students signed a pledge affirming their responsibility as future health care professionals to keep themselves and others safe by modeling responsible COVID-19 pandemic behaviors both on campus and in the community at large.
College of Medicine leaders updated faculty, staff and students on Sept. 18 about the College of Medicine’s ongoing response to the COVID-19 pandemic.
A Penn State College of Medicine research team will continue to work on developing a vaccine for COVID-19 using more than $400,000 in funding from the Pennsylvania Department of Community and Economic Development. The goal is to create a vaccine that can provide long-term, protective immunity.
Kassie Heeman knows she carries a lot of weight on her shoulders. “If I don’t see something, then the doctors don’t see it – and that’s a big deal,” said the Paxtonia resident who is a sonographer at Hershey Medical Center.
Sep 20, 2020
A recent study by Penn State College of Medicine's Jonathan Stine, MD, MSc, shows a promising new way to measure response to treatment in people with early-phase NASH, currently done using more invasive liver biopsy techniques.